Bioceros

About:

Bioceros provides services related to the preclinical development of monoclonal antibodies and generation protein-producing cell lines.

Website: http://www.bioceros.com

Top Investors: Forbion Capital Partners, Thuja Capital

Description:

Bioceros B.V. operates as a biopharmaceutical research and development contract organization. The company focuses on providing a range of technical and scientific expertise ranging from discovery research to pre-clinical development. Its services include assay development and quantification, pre-clinical development, molecular biology, cell biology and immunology, protein expression in various systems, upscaling/fermentation, protein purification, and consulting services. The company offers its services to other biotech companies, academic institutions, and pharmaceutical companies. Bioceros B.V. was founded in 2003 and is based in Utrecht, the Netherlands.